Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome

Name: Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome
SKU: 4831
Availability: InStock

2.0 CME/CE credits

$125.00

Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome

This CME/CE course provides evidence-based guidance on Cannabis Use Disorder (CUD) and Cannabinoid Hyperemesis Syndrome (CHS). It covers clinical presentation, diagnostic criteria, screening tools, cannabis withdrawal, treatment strategies, and management of recurrent nausea and vomiting. Key concepts are introduced and reinforced through clinically relevant case scenarios.

2 CME/CE credits: This course is accredited for physicians, nurse practitioners, nurses and pharmacists.

Category: Uncategorized

Course Overview

Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome
Dates: May 5, 2026 – May 5, 2028
This activity is jointly provided by Global Education Group and The Answer Page.

Target Audience
The educational design of this activity addresses the needs of all healthcare providers.

Educational Objectives
After completing this activity, the participant should be better able to:

Describe the clinical presentation of cannabinoid hyperemesis syndrome
Describe the management of cannabinoid hyperemesis syndrome
List the diagnostic criteria for cannabis use disorder
Describe the management of cannabis use disorder
Describe the clinical features and diagnostic criteria of cannabis withdrawal
Describe the use of the Cannabis Withdrawal Scale to assess withdrawal symptom severity

Statement of Need/Program Overview

This activity is designed to inform healthcare providers about cannabinoid hyperemesis syndrome and cannabis use disorder.

Accreditation Information

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and The Answer Page. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 2.0 contact hours and 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation
Global Education Group designates this continuing education activity for 2.0 contact hour(s) (0.20 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-26-021-H01-P).
This is a knowledge-based activity.

CME/CE Information

Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the activity, score at least 70% on the quizzes within the activity, and complete the activity evaluation. Your certificate will be available via email after completion of the evaluation.

Disclosure of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Fee Information & Refund/Cancellation Policy
There is a fee for this educational activity. All sales are final once the course has been activated. No refunds will be offered.

Term Offering
This activity was released on 5/5/2026 and is valid for 2 years. Requests for credit must be made no later than 5/5/2028.

Faculty

Meredith Fisher-Corn, MD Editor-in-Chief, The Answer Page, Inc.

Dr. Fisher-Corn is a board-certified physician specializing in anesthesiology, perioperative and pain medicine. She received a Bachelor of Science in biomedical engineering from Duke University School of Engineering and a Medical Degree from the Mount Sinai School of Medicine. Following an anesthesiology residency and fellowship at Brigham and Women’s Hospital, Harvard Medical School, she was an attending anesthesiologist at Women and Infants Hospital, Brown University Medical School.

Since 2009, she has served as Editor-in-Chief of The Answer Page, Inc., and has overseen the creation of well over 200 continuing medical education courses in multiple areas of medicine, including Perioperative & Hospital Medicine, and Opioid Prescribing & Risk Management. In addition, she has created more than 20 courses on the endocannabinoid system & the therapeutic use of cannabinoids, including numerous state required courses for The New York State Department of Health, The Florida Medical Association & The Florida Osteopathic Medical Association, The Pennsylvania Department of Health, The Ohio State Medical Association, The Utah Department of Health & Human Resources, The West Virginia Department of Health & Human Resources and The Minnesota Department of Health. At the recommendation of Professor Raphael Mechoulam, PhD, her content had been featured in Israel’s National Healthcare Provider Cannabis Program.

Dr. Fisher-Corn is the recipient of multiple national and international awards for her work in creating accredited educational content in the area of the endocannabinoid system & the therapeutic use of cannabinoids.